Skip to content

Model 483-03 Pacing Lead

by Intermedics, Inc. 510(k)

Active United States

510(k) K844268

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK844268 Date28 Mar 1985ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 22 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
DTB
Device Class
Class III
Regulation
21 CFR Part 870.3680
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Model 483-03 Pacing Lead is a Permanent Pacemaker Electrode, designed for implantation in the cardiovascular system to deliver electrical stimulation to the heart. It facilitates cardiac pacing by transmitting pacing pulses to the myocardium, ensuring proper heart rhythm in patients with bradycardia or conduction disorders.

This device is supplied sterile and intended for single-use implantation within the body. It is classified as a Class III medical device under FDA regulations and has received FDA 510K clearance as substantially equivalent to a predicate device. The lead is compatible with MRI environments under specific conditions, as outlined in its technical documentation, and must be stored according to manufacturer instructions to maintain sterility and functionality.

Other devices from Intermedics, Inc.

See all devices from Intermedics, Inc. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary purpose of the Model 483-03 Pacing Lead, and how does it function in the body?

    The Model 483-03 Pacing Lead is designed to deliver electrical stimulation to the heart muscle (myocardium) during implantation in the cardiovascular system. It facilitates cardiac pacing by transmitting pacing pulses, helping maintain a proper heart rhythm in patients with bradycardia (slow heart rate) or conduction disorders. Essentially, it acts as an electrode to ensure the heart beats consistently when natural electrical signals are insufficient.

  • Is the Model 483-03 Pacing Lead intended for reuse, or is it meant for single-use only?

    The Model 483-03 Pacing Lead is explicitly supplied sterile and intended for single-use implantation within the body. This design ensures patient safety by preventing cross-contamination and maintaining device integrity for one-time use only.

  • How should the Model 483-03 Pacing Lead be stored to preserve its sterility and functionality?

    The lead must be stored according to the manufacturer’s instructions to maintain both sterility and functionality. Since it is supplied sterile, proper storage conditions—such as sealed packaging, controlled humidity, and protection from physical damage—are critical to ensure it remains ready for implantation without contamination or degradation.

  • Can this pacing lead be used in patients who require MRI scans, and if so, are there specific conditions or limitations?

    The Model 483-03 Pacing Lead is compatible with MRI environments under specific conditions, as detailed in its technical documentation. However, these conditions are not specified in the provided data, so clinicians should always refer to the manufacturer’s guidelines or labeling to confirm safe MRI protocols before proceeding. Never assume compatibility without verification.

  • What regulatory pathway was followed for FDA clearance of the Model 483-03 Pacing Lead, and what does this mean for its use?

    The lead received FDA 510(k) clearance under the *Substantially Equivalent* (SESE) determination, meaning it was deemed comparable to a previously approved predicate device (a permanent pacemaker electrode) through a traditional review process. This clearance confirms the device meets FDA safety and effectiveness standards for its intended use in cardiac pacing, but clinicians should always verify current labeling for any updates or additional requirements.